FROM OUR EXPERTS
When a child is put on a feeding tube often the first question a parent wants answered is when they will be able to come off of the tube. This can be a very complicated question and really depends on a myriad of factors. Some of the issues that have to be considered in order to safely wean a child from a tube feeding will be discussed in this article but please understand that this is not an exhaustive list.
One of the first thing to consider when we talk about weaning from a tube feeding is whether the issue that required tube placement had been resolved. If the original issue is still outstanding then removal of the tube may only be temporary and the tube may have to be replaced as soon as the nutritional status again plummets. Making sure that the problem that was addressed by the tube is resolved can help prevent this from happening.
The oral status of the child must be addressed as well. If the child is still having issues with swallowing that may prevent weaning th...
I recently spoke with a friend with diabetes who had just started Prozac. He was amazed to find he was having repeated hypoglycemia within days after starting the drug, and had to cut back on his insulin doses. He obviously wondered if it were somehow due to Prozac.
Prozac has been a wonder drug for the treatment of depression, but it has a possible effect on diabetes that has not been widely recognized. Prozac, a brand name for the drug fluoxetine, was introduced in the 1980's, and was the first in a class of antidepressant medications called SSRIs (selective serotonin reuptake inhibitors). It turns out that Prozac (and other SSRIs) have a possible effect of concern for people with diabetes: they can lower blood glucose enough to require downward adjustment of medications taken for control of diabetes.
I went to the drug's label, as posted at the FDA website. The possibility of hypoglycemia when on Prozac has been in the Prozac label for years. It currently reads :&...
The recent report that Prozac may slow the development of brain lesions is the sort of news that maybe shouldn't be reported at all. It's so preliminary that it's of value almost exclusively to researchers. It appears to invite people with MS to consider taking Prozac to slow the disease. It shouldn't.
Three things you need to know:
1. The Dutch study was very small: 19 people with MS taking Prozac, 19 taking a placebo. Researchers used MRIs every four weeks to monitor development of brain inflammation. At eight weeks fewer new lesions appeared in patients taking Prozac; the difference was sustained for 24 weeks.
2. There was no difference in symptoms or exacerbations related to the two treatments during the tests. But side effects did show themselves: People taking Prozac had more drowsiness and nausea than those who took the placebo.
3. The bottom line here is that there is enough evidence to justify moving ahead with further studies of Prozac (and simila...
You should know
Answers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.